H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 19,312 276 World Ranking 10011 National Ranking 462

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Biochemistry

Fabian Kiessling spends much of his time researching Nanomedicine, Drug delivery, Targeted drug delivery, Angiogenesis and Cancer research. His studies in Nanomedicine integrate themes in fields like Molecular imaging, Clinical trial, Computational biology and Intensive care medicine. Fabian Kiessling combines subjects such as Tumor targeting, Biomedical engineering, Microbubbles and Drug with his study of Drug delivery.

The subject of his Targeted drug delivery research is within the realm of Pharmacology. His work carried out in the field of Angiogenesis brings together such families of science as Receptor tyrosine kinase, Vascular endothelial growth factor, Glioma and Cell biology. His research integrates issues of Cell growth, Hepatic stellate cell, CXCL10, CCL20 and Immunology in his study of Cancer research.

His most cited work include:

  • Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress (871 citations)
  • Vascular normalization in Rgs5-deficient tumours promotes immune destruction (411 citations)
  • MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1 (358 citations)

What are the main themes of his work throughout his whole career to date?

Fabian Kiessling focuses on Pathology, Microbubbles, Biomedical engineering, Molecular imaging and Cancer research. His studies deal with areas such as Magnetic resonance imaging, Ex vivo, Angiogenesis and Vascular endothelial growth factor as well as Pathology. His Microbubbles study integrates concerns from other disciplines, such as Drug delivery and Ultrasound imaging.

Fabian Kiessling focuses mostly in the field of Drug delivery, narrowing it down to matters related to Drug and, in some cases, Nanomedicine. His Molecular imaging research focuses on Medical physics and how it relates to Medical imaging. His Cancer research research is multidisciplinary, incorporating perspectives in Cancer and Immune system.

He most often published in these fields:

  • Pathology (22.25%)
  • Microbubbles (15.46%)
  • Biomedical engineering (15.22%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (13.35%)
  • Molecular imaging (14.99%)
  • Drug delivery (11.24%)

In recent papers he was focusing on the following fields of study:

Fabian Kiessling mainly focuses on Cancer research, Molecular imaging, Drug delivery, Microbubbles and Pathology. His Molecular imaging research includes themes of Big data, Medical physics and Medical imaging. His Targeted drug delivery study, which is part of a larger body of work in Drug delivery, is frequently linked to Context, bridging the gap between disciplines.

In his study, Magnetic resonance imaging is strongly linked to Biomedical engineering, which falls under the umbrella field of Microbubbles. His Pathology study combines topics in areas such as Preclinical imaging, Extracellular matrix and Kidney. His study looks at the relationship between Nanomedicine and fields such as Nanocarriers, as well as how they intersect with chemical problems.

Between 2017 and 2021, his most popular works were:

  • Tumor targeting via EPR: Strategies to enhance patient responses (349 citations)
  • Smart cancer nanomedicine (205 citations)
  • Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. (183 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Biochemistry

His primary areas of investigation include Drug delivery, Nanomedicine, Microbubbles, Biomedical engineering and Cancer research. His work on Targeted drug delivery is typically connected to Methacrylamide as part of general Drug delivery study, connecting several disciplines of science. His Nanomedicine study incorporates themes from Cancer, Immunotherapy, Clinical trial, Intensive care medicine and Nanocarriers.

Fabian Kiessling interconnects Blood flow, Endothelial activation, VCAM-1 and Endothelial dysfunction in the investigation of issues within Microbubbles. Many of his studies on Biomedical engineering involve topics that are commonly interrelated, such as Ultrasound. His work deals with themes such as Immune checkpoint, Cell, Metastasis, Macrophage polarization and FOXP3, which intersect with Cancer research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

Twan Gerardus Gertudis Maria Lammers;F. Kiessling;W.E. Hennink;Gerrit Storm;Gerrit Storm.
Journal of Controlled Release (2012)

1115 Citations

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

Juliana Hamzah;Manfred Jugold;Fabian Kiessling;Paul Rigby.
Nature (2008)

517 Citations

MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1

Andreas Schober;Maliheh Nazari-Jahantigh;Yuanyuan Wei;Kiril Bidzhekov.
Nature Medicine (2014)

496 Citations

MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages

Maliheh Nazari-Jahantigh;Yuanyuan Wei;Heidi Noels;Shamima Akhtar.
Journal of Clinical Investigation (2012)

454 Citations

Tumor targeting via EPR: Strategies to enhance patient responses

Susanne K. Golombek;Jan Niklas May;Benjamin Theek;Lia Appold.
Advanced Drug Delivery Reviews (2018)

442 Citations

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner

Chunfu Zhang;Manfred Jugold;Eva C. Woenne;Twan Lammers.
Cancer Research (2007)

409 Citations

Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis

Amir Abdollahi;Minglun Li;Minglun Li;Gong Ping;Gong Ping;Christian Plathow.
Journal of Experimental Medicine (2005)

400 Citations

Nanotheranostics and image-guided drug delivery: current concepts and future directions.

Twan Lammers;Fabian Kiessling;Wim E. Hennink;Gert Storm.
Molecular Pharmaceutics (2010)

389 Citations

MRI-Based Attenuation Correction for Hybrid PET/MRI Systems: A 4-Class Tissue Segmentation Technique Using a Combined Ultrashort-Echo-Time/Dixon MRI Sequence

Yannick Berker;Jochen Franke;André Salomon;Moritz Palmowski.
The Journal of Nuclear Medicine (2012)

351 Citations

Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation

Marina Talelli;Matthias Barz;Cristianne J.F. Rijcken;Fabian Kiessling.
Nano Today (2015)

341 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Fabian Kiessling

Twan Lammers

Twan Lammers

RWTH Aachen University

Publications: 87

Christian Weber

Christian Weber

Ludwig Maximilian University of Munich

Publications: 67

Xiaoyuan Chen

Xiaoyuan Chen

National University of Singapore

Publications: 56

Wim E. Hennink

Wim E. Hennink

Utrecht University

Publications: 52

Gert Storm

Gert Storm

Utrecht University

Publications: 44

Zhiyuan Zhong

Zhiyuan Zhong

Soochow University

Publications: 42

Fenghua Meng

Fenghua Meng

Soochow University

Publications: 32

Rakesh K. Jain

Rakesh K. Jain

Harvard University

Publications: 29

Maximilian F. Reiser

Maximilian F. Reiser

Ludwig-Maximilians-Universität München

Publications: 28

Paul A. Dayton

Paul A. Dayton

University of North Carolina at Chapel Hill

Publications: 26

Sophie Laurent

Sophie Laurent

University of Mons

Publications: 25

Chao Deng

Chao Deng

Soochow University

Publications: 25

Xiangyang Shi

Xiangyang Shi

Donghua University

Publications: 25

Ning Gu

Ning Gu

Southeast University

Publications: 24

Frank Tacke

Frank Tacke

Charité - University Medicine Berlin

Publications: 23

Peter Carmeliet

Peter Carmeliet

KU Leuven

Publications: 23

Something went wrong. Please try again later.